Tobacco Allergies and Plant Medicine
What I found when I went looking for why rapé kept making things worse
Originally published September 19, 2024. Revised.
I started using rapé to treat chronic sinusitis. For those who haven’t encountered it, rapé is a category of Amazonian snuffs rather than a single substance, prepared in various tribal traditions, most of them built around mapacho (Nicotiana rustica) and the ashes of particular trees. The immediate effect is a forceful clearing of the sinuses, and for a while that felt like exactly what I needed.
Over several years the pattern changed shape. Relief, then congestion worse than before, then relief again. That’s the loop I want to talk about, and it took me a long time to consider that the thing I was reaching for might be the thing making it worse.
Before I get to allergy, I want to deal with the simpler explanation, because it’s the one I’d raise if someone told me this story.
Rapé is a nasal irritant containing a potent tobacco. Profuse mucus, watering eyes and a purging sensation happen to nearly everyone who uses it, and none of that requires an allergy. Repeatedly irritating nasal mucosa produces inflammation, and inflammation produces congestion, which is a rebound loop that anyone who has overused a decongestant spray will recognize. That explanation covers my experience completely without invoking anything immunological. Whatever else is true, I think it’s part of what was happening, and any account that skips past it is doing motivated reasoning.
What made me look further was a set of test results. I have IgE-specific reactions to mugwort, tomato and potato. Mugwort is Asteraceae. Tomato and potato are Solanaceae, the family tobacco belongs to. That’s an interesting shape, and it’s worth being careful about what it means. A positive specific IgE is sensitization, not clinical allergy. Plenty of people carry measurable IgE to things they can eat without difficulty. It tells you the immune system has produced antibodies, not that it will produce symptoms.
The literature on tobacco as an inhaled allergen is genuinely thin, and I want to describe what’s in it accurately rather than lean on the title of a paper.
The paper everyone cites is Ortega and colleagues, published in Annals of Allergy, Asthma and Immunology in 1999. It’s a single case report. The patient was a worker in the Canary Islands with occupational exposure to an aqueous tobacco solution used as a contact insecticide, presenting with rhinoconjunctivitis and urticaria. She already had seasonal allergic rhinoconjunctivitis to mugwort pollen and oral allergy syndrome with avocado. Skin prick tests, conjunctival challenge and serum specific IgE were positive for both green and cured tobacco leaf extract.
The interesting part is the inhibition work. Tobacco, mugwort and tomato extracts each inhibited the binding of the patient’s serum to tobacco leaf. Potato did not. Potato was used as a control inhibitor alongside Alternaria and dust mite, and it behaved like a control. So the tomato connection is in that paper and the potato connection is not, which matters if you’re building a case out of your own lab results the way I was.
There’s a second 1999 paper from the same journal worth knowing about, looking at tobacco sensitivity across patients with asthma, COPD and lung carcinoma. It found a specific IgE response to tobacco, but that response tracked with sensitivity to rye grass pollen rather than to other Solanaceae vegetables. Two papers from the same year point in somewhat different directions about where tobacco cross-reactivity actually lives.
So here’s my honest position. Cross-reactivity between mugwort pollen and tobacco has been demonstrated in at least one well-characterized patient, and I share the mugwort sensitization that patient had. That makes a tobacco reaction plausible in my case. It doesn’t make it demonstrated. The test that would settle it is a tobacco-specific ImmunoCAP, which was used in that study and which I have not been able to find available through commercial labs I’ve searched. I’m working from a plausible mechanism and a symptom pattern, which is where a lot of useful inquiry starts and is not the same thing as knowing.
The route of administration deserves its own attention, separately from allergy.
Substances placed in the nasal cavity aren’t only acting locally. The cribriform plate, the perforated bone above the nasal cavity that olfactory nerves pass through, carries what current reviews describe as the predominant route by which cerebrospinal fluid drains out of the skull into nasal lymphatics. The same anatomy runs in the other direction, which is the basis for intranasal drug delivery reaching the brain along perineural spaces while bypassing the blood-brain barrier. Most of the detailed mapping is from mouse work and the field has been moving quickly, with a nasopharyngeal lymphatic hub described only in 2024.
That’s a reason to take nasal administration seriously as a distinct route rather than as a convenient one. It applies to anything you put up your nose, allergy or no allergy, and it applies to me whether my tobacco hypothesis holds up or not.
Which brings me to the word detox, which gets used to explain away exactly the symptoms that ought to prompt a second look. A forceful purge is not evidence of toxins leaving. Streaming mucus and watering eyes are what mucous membranes do when something irritating lands on them. That reading is available for free and requires no theory. When a practice reliably produces a dramatic physical response, and that response gets pre-interpreted as healing, you have built a system that cannot tell you when to stop.
If you want to investigate whether you have Solanaceae or cross-reactive sensitization, the tools are ordinary. Specific IgE blood testing, often ImmunoCAP, covers tomato, potato and mugwort. Skin prick testing is at least as useful and is generally the first-line approach in allergy practice, not a lesser substitute for blood work, and the two are complementary rather than ranked. For the food members of the family, a structured elimination and reintroduction can tell you about clinical reactivity in a way that neither test does, since sensitization and symptoms are different questions. Tobacco-specific testing is the gap, and I haven’t found a good answer for it.
On treatment I want to be more careful than I was.
Acupuncture has a modest but real evidence base for allergic rhinitis, and it appears in mainstream allergy practice parameters as an option worth considering. If that’s a direction you’re drawn to, it’s a defensible one.
I’ve also spent time with NAET and with Advanced Allergy Therapeutics, and I’m not going to recommend them the way I once would have. Both rest on applied kinesiology, the practice of testing muscle strength while a patient holds a vial of a suspected allergen. That specific diagnostic claim has been tested repeatedly and does not identify allergens at better than chance. The evidence offered for the treatment side is case reports. I don’t think that makes these practices worthless as an experience, and I know people who feel they’ve been helped. But the failure mode is specific and worth naming: a method that tells you an allergy has been cleared, when the underlying IgE response hasn’t changed, invites you to stop avoiding something you should still be avoiding. For food and venom allergy that gap is dangerous. For a nasal snuff it’s less acute, and the logic is the same.
I’d rather say that plainly than dress it up, given that the whole argument of this piece is that the plant medicine world tends to accept flattering explanations too easily.
What predicts trouble, as far as I can tell, is a short list. Existing sensitization to mugwort or to Solanaceae foods. A history of allergic rhinitis. And frequency, because a weekly ceremony and a daily habit are not the same exposure. Beyond that, most of what gets asserted about who will and won’t react is confident guessing, mine included.
The traditional use of these medicines in Amazonian contexts is real and I’m not arguing with it. What doesn’t follow is that a practice developed within one population, one climate and one relationship to a plant transfers unchanged to someone with a different history and a different immune system. That’s not a criticism of the tradition. It’s a caution about how we import things.
The lesson I actually took from this is smaller and more useful than a diagnosis. If a medicine helps every time and the underlying problem keeps getting worse, the pattern is the information. I spent years reading the relief as evidence and treating the deterioration as something separate. It wasn’t separate. It was the same loop, and I was in the middle of it holding a tepi.
References
Ortega, N., Quiralte, J., Blanco, C., Castillo, R., Alvarez, M. J., & Carrillo, T. (1999). Tobacco allergy: demonstration of cross-reactivity with other members of Solanaceae family and mugwort pollen. Annals of Allergy, Asthma & Immunology, 82(2), 194-197.
Ortega Rodríguez, N., et al. (1999). Tobacco as an allergen in bronchial disease. Annals of Allergy, Asthma & Immunology, 82(2).
Spera, I., et al. (2023). Open pathways for cerebrospinal fluid outflow at the cribriform plate along the olfactory nerves. eBioMedicine, 91, 104558.
Yoon, J.-H., et al. (2024). Nasopharyngeal lymphatic plexus is a hub for cerebrospinal fluid drainage. Nature, 625, 768-777.
